Breaking News Instant updates and real-time market news.

TLRY

Tilray

$36.38

-2.745 (-7.02%)

10:25
08/15/19
08/15
10:25
08/15/19
10:25

Tilray call volume above normal and directionally bullish

Bullish option flow detected in Tilray with 12,150 calls trading, 5x expected, and implied vol increasing almost 2 points to 72.96%. Aug-19 40 calls and Sep-19 30 puts are the most active options, with total volume in those strikes near 6,000 contracts. The Put/Call Ratio is 0.50. Earnings are expected on November 13th.

TLRY Tilray
$36.38

-2.745 (-7.02%)

07/17/19
LTCO
07/17/19
INITIATION
LTCO
Neutral
Tilray initiated with a Neutral at Ladenburg
Ladenburg Thalmann analyst Glenn Mattson started Tilray with a Neutral rating. Within the cannabis space, the analyst favors Canadian companies who are focused on long-term value creation and gaining market share as well as those with a well-defined plan for potentially entering the U.S. market. He initiated coverage on the cannabis space with a "bullish long-term outlook." A significant portion of Tilray's near-term growth is a result of its Manitoba acquisition, which is mainly an organic foods company, as opposed to growth from cannabis, Mattson tells investors in a research note.
08/14/19
STFL
08/14/19
NO CHANGE
Target $38
STFL
Hold
Stifel keeps Hold rating, $38 price target on Tilray after Q2 report
Stifel analyst W. Andrew Carter said Tilray's Q2 revenue performance exceeded his expectations and he believes the company's report underscores the cannabis industry's preeminent theme - namely, robust revenue growth opportunity bumping up against a high degree of investment needed to capitalize on a "once-in-a-lifetime" opportunity. Following the report, he increased his FY19 gross revenue estimate to $171M, but lowered his EBITDA estimates to conform more closely to the company's guidance. Carter keeps a Hold rating and $38 price target on Tilray shares, but said he thinks the stock could come under pressure as he believes investors may focus on the wider than expected EBITDA losses.
08/14/19
BNCH
08/14/19
NO CHANGE
Target $80
BNCH
Buy
Tilray price target lowered to $80 from $200 at Benchmark
Benchmark analyst Mike Hickey lowered his price target on Tilray shares to $80 from $200 after the company reported "mixed" Q2 results. The company's "near term profitability aspirations have been abandoned" as Tilray seeks to take additional market share, said Hickey, who remains cautious on the Canadian regulatory regime and expects on-going supply and distribution constraints. However, he keeps a Buy rating on Tilray shares.
08/15/19
VERF
08/15/19
NO CHANGE
Target $4
VERF
Sell
Vertical Group sees 90% downside in Tilray, says 'back up truck' to short
It is time to "back up the truck" and short shares of Tilray, Vertical Group analyst Gordon Johnson tells investors in a research note. The analyst introduced a year-end 2020 price target of $4, which implies around 90% downside to Tilray's closing price Wednesday of $39.04. The company's top shareholder, Privateer, is set to unload its 72% position over the course of this year and next, Johnson points out. Further, the analyst calls Tilray's Q2 results "horrific." On top of that, the company, which only has two-to-three quarters of cash left, admitted its results are slated to get worse, adds Johnson. The analyst says that in his years covering stocks, he's rarely seen such a richly valued company.

TODAY'S FREE FLY STORIES

05:20
09/17/19
09/17
05:20
09/17/19
05:20
General news
Oil Action: Crude prices have steadied as developments are awaited »

Oil Action: Crude prices…

SAPMY

Saipem

$0.00

(0.00%)

05:18
09/17/19
09/17
05:18
09/17/19
05:18
Downgrade
Saipem rating change  »

Saipem downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESALY

Eisai

$0.00

(0.00%)

05:16
09/17/19
09/17
05:16
09/17/19
05:16
Downgrade
Eisai rating change  »

Eisai downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

MMSI

Merit Medical

$28.77

1.12 (4.05%)

05:13
09/17/19
09/17
05:13
09/17/19
05:13
Recommendations
Merit Medical analyst commentary  »

Piper cuts Merit Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHAK

Shake Shack

$100.80

0.8 (0.80%)

05:09
09/17/19
09/17
05:09
09/17/19
05:09
Recommendations
Shake Shack analyst commentary  »

Shake Shack price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNTA

Momenta

$14.10

0.33 (2.40%)

05:09
09/17/19
09/17
05:09
09/17/19
05:09
Recommendations
Momenta analyst commentary  »

Momenta risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

SEAS

SeaWorld

$30.09

-0.01 (-0.03%)

04:59
09/17/19
09/17
04:59
09/17/19
04:59
Recommendations
SeaWorld analyst commentary  »

SeaWorld selloff on CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$101.76

4.35 (4.47%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Ligand management to meet with Craig-Hallum »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 20

    Sep

  • 02

    Oct

  • 13

    Nov

SGC

Superior Uniform

$16.39

-0.21 (-1.27%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Superior Uniform management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

WIRE

Encore Wire

$60.43

0.55 (0.92%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Encore Wire management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

V

Visa

$176.12

-1.16 (-0.65%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Visa management to meet with Evercore ISI »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 23

    Sep

  • 27

    Oct

EQIX

Equinix

$550.00

13.42 (2.50%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Equinix management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 16

    Dec

04:55
09/17/19
09/17
04:55
09/17/19
04:55
General news
Industrial Production to be reported at 09:15 »

August Industrial…

TRIP

TripAdvisor

$41.14

0.35 (0.86%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
TripAdvisor management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

04:55
09/17/19
09/17
04:55
09/17/19
04:55
General news
Industrial Production Capacity Utilization Rate to be reported at 09:15 »

August Industrial…

UCBI

United Community Banks

$27.93

-0.115 (-0.41%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
United Community Banks management to meet with Sandler ONeill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 13

    Nov

JAZZ

Jazz Pharmaceuticals

$133.80

2.35 (1.79%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Jazz Pharmaceuticals management to meet with Oppenheimer »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

TNXP

Tonix Pharmaceuticals

$0.49

0.0136 (2.89%)

, NEPH

Nephros

$7.59

(0.00%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Microcap to hold a summit »

Fall Investor Summit 2019…

TNXP

Tonix Pharmaceuticals

$0.49

0.0136 (2.89%)

NEPH

Nephros

$7.59

(0.00%)

RESN

Resonant

$3.07

0.03 (0.99%)

ZOM

Zomedica

$0.42

-0.0313 (-6.96%)

MYSZ

MySize

$0.49

0.0186 (3.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 01

    Oct

  • 12

    Nov

CTLT

Catalent

$50.62

-0.71 (-1.38%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Catalent management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

CDK

CDK Global

$46.88

0.61 (1.32%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
CDK Global management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

AMED

Amedisys

$130.73

-2.13 (-1.60%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Amedisys management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 19

    Sep

  • 13

    Nov

AB

AllianceBernstein

$29.68

0.08 (0.27%)

, AFIN

American Finance Trust

$13.60

0.24 (1.80%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
NAREIT to hold a forum »

NAREIT SFO Forum 2019…

AB

AllianceBernstein

$29.68

0.08 (0.27%)

AFIN

American Finance Trust

$13.60

0.24 (1.80%)

AMT

American Tower

$216.74

1.455 (0.68%)

BXP

Boston Properties

$132.04

0.5 (0.38%)

C

Citi

$69.83

-0.54 (-0.77%)

COF

Capital One

$94.39

0.79 (0.84%)

CXP

Columbia Property

$21.41

0.04 (0.19%)

DUK

Duke Energy

$93.13

-0.83 (-0.88%)

HST

Host Hotels

$17.40

0.07 (0.40%)

KIM

Kimco Realty

$20.00

-0.13 (-0.65%)

KRC

Kilroy Realty

$76.98

1.02 (1.34%)

MFG

Mizuho Financial Group

$3.12

-0.04 (-1.27%)

PLD

Prologis

$85.28

1.065 (1.26%)

REG

Regency Centers

$68.26

0.16 (0.23%)

RPAI

Retail Properties of America

$11.96

0.04 (0.34%)

SLG

SL Green Realty

$81.96

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 19

    Sep

  • 25

    Sep

  • 26

    Sep

  • 02

    Oct

  • 15

    Oct

  • 24

    Oct

  • 27

    Oct

  • 30

    Oct

  • 31

    Oct

  • 10

    Nov

  • 10

    Nov

FMC

FMC Corporation

$91.02

-0.025 (-0.03%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
FMC Corporation management to meet with Stephens »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 30

    Oct

ORA

Ormat Technologies

$71.94

-0.27 (-0.37%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Ormat Technologies management to meet with Oppenheimer »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

TITN

Titan Machinery

$15.19

0.11 (0.73%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Titan Machinery management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.